AMYLIN

22:00:02
Precio12,20
Variación-1,53%
Var.-0,19$
Vol (títulos): 7.245.854
Vol ($): 77.379.528,74

Noticias
PARIS (Reuters) - Stock index futures pointed to a higher open on Wall Street on Monday, with futures for the S&P 500 up 0.29 percent, Dow Jones futures up 0.31 percent and Nasdaq 100 futures up 0.3 percent at 5 a.m. EDT.
  • 2/07
2012-07-02 10:19:30
(Reuters) - La farmacéutica estadounidense Bristol-Myers Squibb acordó la adquisición de Amylin Pharmaceuticals por unos 5.300 millones de dólares (4.220 millones de euros), o 31 dólares por acción, en efectivo.
  • 30/06
2012-06-30 09:52:44
(Reuters) - Bristol-Myers Squibb Co has agreed to buy biotechnology company Amylin Pharmaceuticals Inc for about $5.3 billion, or $31 per share, in cash, giving Bristol-Myers a stake in the future of diabetes drugs Byetta and Bydureon.
  • 30/06
2012-06-30 03:33:50
(Reuters) - Bristol-Myers Squibb Co agreed to buy Amylin Pharmaceuticals Inc for about $5.3 billion, or for $31 per share in cash.
  • 30/06
2012-06-30 03:15:53
By Paritosh Bansal and Soyoung Kim
  • 22/04
2012-04-22 22:51:04
NEW YORK (Reuters) - Amylin Pharmaceuticals Inc , which spurned a $3.5 billion takeover bid from Bristol-Meyers Squibb Co and is fending off activist investor Carl Icahn, is exploring a sale, sources familiar with the situation said on Sunday.
  • 22/04
2012-04-22 20:31:48
By Jonathan Stempel
  • 9/04
2012-04-09 20:32:14
(Reuters) - Shares of Amylin Pharmaceuticals Inc rose as much as 51 percent on Wednesday after Bloomberg News reported the company rejected a $3.5 billion unsolicited takeover bid from Bristol-Myers Squibb Co .
  • 28/03
2012-03-28 15:34:45
By Bill Berkrot
  • 21/04
2009-04-21 21:20:36

Este comunicado de prensa contiene declaraciones prospectivas sobre Amylin y Lilly. Los resultados reales podrían diferir de los comentados o contenidos en este comunicado debido a una serie de riesgos e incertidumbres, incluyendo el riesgo de que exenatide y los ingresos generados de exenatide podrían verse afectados...

  • 27/08
2008-08-27 13:00:42

SAN DIEGO e INDIANAPOLIS, August 27 /PRNewswire/ --

Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) y Eli Lilly and Company (NYSE: LLY), en una rueda de prensa celebrada hoy, han proporcionado el contexto y la información adicional relacionada con la actualización del 18 de agosto de 2008 de la Administración...

  • 27/08
2008-08-27 13:00:36